A. “Variant of TREM2 Associated with the Risk of Alzheimer’s Disease,” by Thorlakur Jonsson, Hreinn Stefansson, Stacy Steinberg, Ingileif Jonsdottir, Palmi V. Jonsson, Jon Snaedal, Sigurbjorn Bjornsson, Johanna Huttenlocher, Allan I. Levey, James J. Lah, Dan Rujescu, Harald Hampel, Ina Giegling, Ole A. Andreassen, Knut Engedal, Ingun Ulstein, Srdjan Djurovic, Carla Ibrahim-Verbaas, Albert Hofman, M. Arfan Ikram, Cornelia M van Duijn, Unnur Thorsteinsdottir, Augustine Kong, and Kari Stefansson (Vol. 368, No. 2, January 10, 2013, p. 107-116).
www.nejm.org/doi/full/10.1056/NEJMoa1211103#t=abstract
B. “TREM2 Variants in Alzheimer’s Disease,” by Rita Guerreiro, Aleksandra Wojtas, Jose Bras, Minerva Carrasquillo, Ekaterina Rogaeva, Elisa Majounie, Carlos Cruchaga, Celeste Sassi, John S.K. Kauwe, Steven Younkin, Lilinaz Hazrati, John Collinge, Jennifer Pocock, Tammaryn Lashley, Julie Williams, Jean-Charles Lambert, Philippe Amouyel, Alison Goate, Rosa Rademakers, Kevin Morgan, John Powell, Peter St. George-Hyslop, Andrew Singleton, and John Hardy, for the Alzheimer Genetic Analysis Group (Vol. 368, No. 2, January 10, 2013, p. 117-127).
